Nanomaterials: An innovative integrative paradigm for hepatocellular carcinoma adjuvant treatment
Asian Journal of Pharmaceutical Sciences · 2026-06 · 21 (3) · 101151
DOI: 10.1016/j.ajps.2026.101151 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Asian Journal of Pharmaceutical Sciences, 2026-06. Verfasst von Qingqing Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Cancer Institute, Center for Translational Medicine, Naval Medical University, Shanghai 200433, China. Die Arbeit nennt 206 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Heilongjiang Province Natural Science Foundation, Shanghai Municipal Natural Science Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinical Cancer Institute, Center for Translational Medicine, Naval Medical University, Shanghai 200433, China.
- Changhai Clinical Research Unit, Shanghai Changhai Hospital, Naval Medical University, Shanghai 200433, China.
- Shanghai Key Laboratory of Nautical Medicine and Translation of Drugs and Medical Devices, Shanghai 200336, China.
- Department of Pharmacy, Shanghai Changhai Hospital, the First Affiliated Hospital of Naval Medical University, Shanghai 200433, China.
Förderung
- National Natural Science Foundation of China
- Heilongjiang Province Natural Science Foundation
- Shanghai Municipal Natural Science Foundation
- Shanghai Municipal Education Commission
- Program for Professor of Special Appointment Eastern Scholar at Shanghai Institutions of Higher Learning
Zitieren
APA
Yang, Q., Zhang, W., Ji, K., Wang, Z., Gao, J., & Ding, J. (2026). Nanomaterials: An innovative integrative paradigm for hepatocellular carcinoma adjuvant treatment. Asian Journal of Pharmaceutical Sciences, 21(3), 101151. https://doi.org/10.1016/j.ajps.2026.101151
Vancouver
Yang Q, Zhang W, Ji K, Wang Z, Gao J, Ding J. Nanomaterials: An innovative integrative paradigm for hepatocellular carcinoma adjuvant treatment. Asian Journal of Pharmaceutical Sciences. 2026;21(3):101151. doi:10.1016/j.ajps.2026.101151
BibTeX
@article{Yang2026,
author = {Yang, Qingqing and Zhang, Wen and Ji, Keqin and Wang, Zhuo and Gao, Jie and Ding, Jin},
title = {Nanomaterials: An innovative integrative paradigm for hepatocellular carcinoma adjuvant treatment},
journal = {Asian Journal of Pharmaceutical Sciences},
year = {2026},
volume = {21},
number = {3},
pages = {101151},
doi = {10.1016/j.ajps.2026.101151}
}
EUVIMED